How to get the most out of your appointments: Physician and patient perspectives with Dr. Greenberg and Kristin Smith
September 25, 2017, EDT @ 1:00 pm, EDT - 2:00 pm, EDT
SEND US YOUR QUESTIONS FOR THE EXPERTS HERE
(During the podcast, you can interact with the moderator through our TMA Facebook page, or using the chat function in GoToWebinar)
Benjamin M. Greenberg, MD, MHS
Dr. Benjamin Greenberg received his Bachelor of Arts degree from Johns Hopkins University and his Masters Degree in Molecular Microbiology and Immunology from the Johns Hopkins School of Public Health in Baltimore, Maryland. He attended medical school at Baylor College of Medicine in Houston, Texas. Then, he completed an internship in medicine at Rush Presbyterian-St. Lukes Medical Center in Chicago, Illinois before going on to his residency in neurology at The Johns Hopkins Hospital in Baltimore, MD. He then joined the faculty within the division of neuroimmunology at Hopkins and became the co-director of the Transverse Myelitis Center and director of the Encephalitis Center. In January of 2009 he was recruited to the faculty at the University of Texas Southwestern Medical Center where he was named Deputy Director of the Multiple Sclerosis Program and Director of the new Transverse Myelitis and Neuromyelitis Optica Program. That same year he established the Pediatric Demyelinating Disease Program at Children’s Medical Center Dallas.
Dr. Greenberg is recognized internationally as an expert in rare autoimmune disorders of the central nervous system (e.g. transverse myelitis, neuromyelitis optica, ADEM and autoimmune encephalitis). He splits his clinical time between seeing both adult and pediatric patients. He routinely consults on the inpatient units of University Hospital, Zale Lipshy, Parkland and Children’s. His research interests are in both the diagnosis and treatment of transverse myelitis, neuromyelitis optica, encephalitis, multiples sclerosis and infections of the nervous system. He is actively involved in developing better ways to diagnose and prognosticate for patients with these disorders. He has led an effort to improve biorepository development and has created uniform protocols for sample handling and analysis. As part of this initiative his research has identified novel biomarkers that may be able to distinguish between patients with various neurologic disorders. He also coordinates trials that study new treatments to prevent neurologic damage and restore function to those who have already been affected. He currently serves as the Director of the Neurosciences Clinical Research Center and is a Cain Denius Foundation Scholar.
Kristin Smith began losing sensation in both legs on December 20, 2012, and in a matter of a few hours, she was paralyzed from the chest down. Three months after Kristin lost the ability to walk, she was diagnosed with transverse myelitis. Still requiring the use of her wheelchair, she was determined not to give up her dreams. Kristin has since completed her Master’s and PhD in Atmospheric Science at the University of Maryland and now works at the National Aeronautics and Space Administration in Florida.
September 2017 TMA Ask the Expert Podcast Series sponsored in part by
Alexion is a global biopharmaceutical company focused on serving patients with severe and rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Their goal to deliver medical breakthroughs where none currently exist is driven by the knowledge that people’s lives depend on their work.
* The Executive Committee of the TMA with the medical and scientific council determines the content and topics of the podcasts. Sponsors are not able to influence the education program.
Listen to previous Ask the Expert podcasts here